Literature DB >> 9388048

Expression of thrombin receptors in human atherosclerotic coronary arteries leads to an exaggerated vasoconstrictory response in vitro.

D D Ku1, J Dai.   

Abstract

Alpha-thrombin can alter vascular tone by proteolytic cleavage of its cell-surface receptor, which exposes a tethered peptide sequence, Ser-Phe-Leu-Leu-Arg-Asn (SFLLRN) that activates the receptor. We investigated the effects of increasing severity of coronary atherosclerosis on SFLLRN-induced responses on 165 human coronary artery rings isolated fresh from 15 patients who underwent cardiac transplantation. In 40 coronary rings with minimal intimal proliferation, addition of 0.001-5 microM SFLLRN resulted in a dose- and endothelium-dependent relaxation reaching a maximum of -87.0 +/- 2.3% (mean +/- SEM) and median inhibitory concentration (IC50) of 0.1 microM. Increasing severity of atherosclerotic lesion, as determined by morphometric quantification of intimal thickening under light microscopy, resulted in graded decreases in both sensitivity and magnitude of the observed relaxation. The maximal relaxations in coronary arteries with mild and moderate intimal proliferation were -76.7 +/- 3.5% (mean +/- SEM of 41 rings) and -63.6 +/- 6.4% (mean +/- SEM of 22 rings), respectively. In the 21 coronary rings with severe intimal proliferation, no significant SFLLRN-induced relaxation was noted. Mechanical disruption of intimal endothelium abolished the SFLLRN-induced relaxation observed in the minimal to mild intimally thickened arteries, whereas in arteries with moderate and severe intimal thickening, a significant SFLLRN-induced contraction (19 +/- 10% and 43 +/- 7%, respectively) was observed. Similar endothelium-dependent relaxations in minimal atherosclerotic and endothelium-independent contraction in severe atherosclerotic coronary arteries were also observed with alpha-thrombin. These findings confirm a recent in situ hybridization and immunohistochemistry study reporting localization of cloned thrombin receptors only in endothelium of "normal appearing" human abdominal aortae and induced expression of thrombin receptors in intimal/medial regions of the atherosclerotic vessels and further demonstrate that similar expression of thrombin receptors in human atherosclerotic coronary arteries leads to an unmasking of a marked vasoconstrictory response.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9388048     DOI: 10.1097/00005344-199711000-00016

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  12 in total

1.  Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis.

Authors:  Rajashree Rana; Tianfang Huang; Georgios Koukos; Elizabeth K Fletcher; Susan E Turner; Andrew Shearer; Paul A Gurbel; Jeffrey J Rade; Carey D Kimmelstiel; Kevin P Bliden; Lidija Covic; Athan Kuliopulos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-04-05       Impact factor: 8.311

2.  Thrombin induced connective tissue growth factor expression in rat vascular smooth muscle cells via the PAR-1/JNK/AP-1 pathway.

Authors:  Wen-chin Ko; Bing-chang Chen; Ming-jen Hsu; Chia-ti Tsai; Chuang-ye Hong; Chien-huang Lin
Journal:  Acta Pharmacol Sin       Date:  2012-01       Impact factor: 6.150

3.  Increased expression of matrix metalloproteinase-1 in systemic vessels of preeclamptic women: a critical mediator of vascular dysfunction.

Authors:  Guadalupe Estrada-Gutierrez; Renato E Cappello; Nikita Mishra; Roberto Romero; Jerome F Strauss; Scott W Walsh
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

4.  Plasma kallikrein promotes epidermal growth factor receptor transactivation and signaling in vascular smooth muscle through direct activation of protease-activated receptors.

Authors:  Rany T Abdallah; Joo-Seob Keum; Hesham M El-Shewy; Mi-Hye Lee; Bing Wang; Monika Gooz; Deirdre K Luttrell; Louis M Luttrell; Ayad A Jaffa
Journal:  J Biol Chem       Date:  2010-09-08       Impact factor: 5.157

5.  Thrombin activation of proteinase-activated receptor 1 potentiates the myofilament Ca2+ sensitivity and induces vasoconstriction in porcine pulmonary arteries.

Authors:  Jun Maki; Mayumi Hirano; Sumio Hoka; Hideo Kanaide; Katsuya Hirano
Journal:  Br J Pharmacol       Date:  2010-01-28       Impact factor: 8.739

6.  Protease-Activated Receptor 1 in Human Carotid Atheroma Is Significantly Related to Iron Metabolism, Plaque Vulnerability, and the Patient's Age.

Authors:  Wei Li; Ehab Osman; Claes Forssell; Xi-Ming Yuan
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

7.  Up-regulation of proteinase-activated receptor 1 and increased contractile responses to thrombin after subarachnoid haemorrhage.

Authors:  Y Maeda; K Hirano; Y Kai; M Hirano; S O Suzuki; T Sasaki; H Kanaide
Journal:  Br J Pharmacol       Date:  2007-09-03       Impact factor: 8.739

8.  Proteinase-activated receptor-1 (PAR-1) activation contracts the isolated human renal artery in vitro.

Authors:  Michele Tognetto; Michael R D'Andrea; Marcello Trevisani; Remo Guerrini; Severo Salvadori; Lorella Spisani; Carlo Daniele; Patricia Andrade-Gordon; Pierangelo Geppetti; Selena Harrison
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

9.  Protein targets of inflammatory serine proteases and cardiovascular disease.

Authors:  Ram Sharony; Pey-Jen Yu; Joy Park; Aubrey C Galloway; Paolo Mignatti; Giuseppe Pintucci
Journal:  J Inflamm (Lond)       Date:  2010-08-30       Impact factor: 4.981

Review 10.  Biased signaling of protease-activated receptors.

Authors:  Peishen Zhao; Matthew Metcalf; Nigel W Bunnett
Journal:  Front Endocrinol (Lausanne)       Date:  2014-05-13       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.